COMMUNIQUÉS West-GlobeNewswire

Organovo Announces Appointment of Steven G. Hughes, M.D. as Chief Medical Officer
01/08/2018
SAN DIEGO, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that Steven G. Hughes has been named Chief Medical Officer. Dr. Hughes is an industry veteran who brings [...]
Catalyst Pharmaceuticals to Hold Second Quarter Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 8th, 2018
01/08/2018
CORAL GABLES, Fla., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
Foamix Pharmaceuticals to Announce Second Quarter Financial Results on August 8
01/08/2018
REHOVOT, Israel, and BRIDGEWATER, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]
Pieris Pharmaceuticals to Host Second Quarter 2018 Investor Call and Corporate Update on August 9, 2018
01/08/2018
BOSTON, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) , a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for cancer, [...]
Andrea Hartong, CNOR, CLNC is Elected to the American Health Council’s Nurse Board
01/08/2018
NEW YORK, Aug. 01, 2018 (GLOBE NEWSWIRE) -- The American Health Council proudly announces the election of Andrea Hartong, CNOR, CLNC to their Nursing Board for her examples of healthcare excellence. For the past 20 [...]
Osiris Therapeutics, Inc. to Re-list on The Nasdaq Global Market on August 1, 2018
01/08/2018
COLUMBIA, Md., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, [...]
Next Generation nVNS Therapy gammaCore Sapphire™ Now Available for Patients with Migraine and Episodic Cluster Headache in United States
01/08/2018
Innovative technology provides patients with convenient, easy-to-use treatment option without the potential side effects associated with commonly prescribed medicines BASKING RIDGE, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE [...]
VBL Therapeutics to Report Second Quarter 2018 Financial Results on August 16
01/08/2018
TEL AVIV, Israel, Aug. 01, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]
Chimerix to Announce Second Quarter 2018 Financial Results on August 8, 2018
01/08/2018
DURHAM, N.C., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that it will host a live conference call [...]
Selecta Biosciences Announces Date of Second Quarter 2018 Financial Results Conference Call
01/08/2018
WATERTOWN, Mass., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]
Kannalife Sciences Finalizes Share Exchange Agreement with TYG Solutions Corp.
01/08/2018
NEW YORK, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc. (“Kannalife”), a bio-pharmaceutical and phyto-medical company, is pleased to announce the completion of a share exchange transaction with TYG [...]
Progressive Care Earns Coveted LegitScript Certification Verifying PharmCo Pharmacy is a Safe and Credible Online Health Resource
01/08/2018
MIAMI, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that its subsidiary, PharmCo, LLC , has received certification [...]
Zogenix to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 6
01/08/2018
EMERYVILLE, Calif., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that it [...]
Atara Biotherapeutics Announces Second Quarter 2018 Financial Results and Recent Operational Progress
01/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Clearside Biomedical to Report Second Quarter 2018 Financial Results on August 8, 2018 – Conference Call to Follow
01/08/2018
ALPHARETTA, Ga., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
MPX Receives Final Licensing Approval for Two Managed Dispensaries in Maryland
01/08/2018
TORONTO, Aug. 01, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF) is pleased to announce the Company, through its indirect wholly-owned subsidiary, S8 Management [...]
KemPharm to Present at Canaccord Genuity 38th Annual Growth Conference
01/08/2018
CORALVILLE, Iowa, Aug. 01, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that its president [...]
Intellia Therapeutics Announces Second Quarter 2018 Financial Results
01/08/2018
Continued to progress lead in vivo program in transthyretin amyloidosis targeting submission of an Investigational New Drug application by the end of 2019 Announced first wholly owned ex vivo T cell receptor program [...]
Neos Therapeutics to Host Second Quarter 2018 Financial Results Conference Call on August 8, 2018
01/08/2018
DALLAS and FORT WORTH, Texas, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) [...]

Pages